Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome
Abstract
Purpose Women with polycystic ovary syndrome are hyperandrogenemic and insulin resistant, which are associated with alterations in circulating lipid and lipoprotein levels. We sought to determine the prevalence of, and risk factors for, lipid abnormalities in these women.Subjects and methods Non-Hispanic white women with polycystic ovary syndrome (n = 195) and ethnically matched control women (n = 62) had fasting blood obtained for hormone and lipid levels. Subjects were categorized by body mass index (nonobese <27 kg/m(2), obese > or =27 kg/m(2)), and analyses were adjusted for age.Results Total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels increased significantly in obese women with polycystic ovary syndrome (n = 153) compared with obese control women (n = 35; mean difference in total cholesterol level = 29 mg/dL; 95% confidence interval [CI]: 14 to 45 mg/dL; P <0.001; mean difference in LDL-C level = 16 mg/dL; 95% CI: 4 to 30 mg/dL; P = 0.006). Similarly, total cholesterol and LDL-C levels increased significantly in nonobese women with polycystic ovary syndrome (n = 42) compared with nonobese control women (n = 27; mean difference in total cholesterol = 32 mg/dL; 95% CI: 13 to 52 mg/dL; P <0.001; mean difference in LDL-C level = 32 mg/dL; 95% CI: 15 to 52 mg/dL; P <0.001). In obese women, high-density lipoprotein cholesterol (HDL-C) and triglyceride levels increased significantly in women with polycystic ovary syndrome compared with control women (mean difference in HDL-C level = 6 mg/dL; 95% CI: 2 to 12 mg/dL; P = 0.002; mean difference in triglyceride level = 34 mg/dL; 95% CI: 1 to 77 mg/dL; P = 0.04). Differences in LDL-C and HDL-C levels, but not triglyceride levels, remained significant after adjusting for alcohol intake, smoking, and exercise. Although age, body mass index, and polycystic ovary syndrome status were significant predictors of lipid levels, these factors accounted for no more than 25% of the variance.Conclusions In this large study of non-Hispanic white women, elevations in LDL-C levels were the predominant lipid abnormality in women with polycystic ovary syndrome, independent of obesity. The characteristic dyslipidemia of insulin resistance was absent. Indeed, obese women with polycystic ovary syndrome had relatively elevated HDL-C levels, which may confer some protection against cardiovascular disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased susceptibility to obesity may further exacerbate insulin resistance and metabolic dysfunctions in PCOS.
“whilst their increased susceptibility to obesity [16] may further exacerbate IR and the accompanying metabolic [17, 18] and reproductive [10, 19] dysfunctions.”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [17]
In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD have been noted and are related to IR and obesity.
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [86]
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555 · see citing works
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801 · see citing works
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · see citing works
Self-citationPOLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
POLSON, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 899 · see citing works
NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-83 · Cited by 815 · see citing works
Legro, R. S., Finegood, D. T., & Dunaif, A. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5054 · Cited by 748 · see citing works
Self-citationHigh density lipoprotein cholesterol and mortality. The Framingham Heart Study.
Wilson, P. W. F., Abbott, R. D., & Castelli, W. P. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.6.737 · Cited by 644 · see citing works
Dunaif, A. E., Scott, D., Finegood, D. T., Quintana, B., & Whitcomb, R. W. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 560 · see citing works
Self-citationTalbott, E. O., Guzick, D. S., Sutton-Tyrrell, K., McHugh-Pemu, K. P., Zborowski, J. V., Remsberg, K. E., & Kuller, L. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2414 · Cited by 511 · see citing works
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504 · see citing works
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
Talbott, E. O., Guzick, D. S., Clerici, A., Berga, S. L., Detre, K. M., Weimer, K., & Kuller, L. H. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.821 · Cited by 499 · see citing works
Lipoprotein Lipid Concentrations and Cardiovascular Risk in Women with Polycystic Ovary Syndrome
Wild, R. A., Painter, P. C., Coulson, P. B., CARRUTH, K. B., & Ranney, G. B. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-5-946 · Cited by 480 · see citing works
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
Conway, G. S., Agrawal, R., Betteridge, D. J., & Jacobs, H. S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02295.x · Cited by 423 · see citing works
Habershon, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)93067-6 · Cited by 368 · see citing works
Plasma Lipoprotein Levels as Predictors of Cardiovascular Death in Women
Bass, K. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410190045006 · Cited by 331 · see citing works
Talbott, E. O., Clerici, A., Berga, S. L., Kuller, L. H., Guzick, D. S., Detre, K. M., Daniels, T. L., & Engberg, R. A. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00010-9 · Cited by 312 · see citing works
Plasma lipoprotein levels as predictors of cardiovascular death in women
Bass, K. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.19.2209 · Cited by 286 · see citing works
Prevalence of High Blood Cholesterol Among US Adults
Sempos, C. T. (1993) · JAMA · doi:10.1001/jama.1993.03500230091035 · Cited by 239 · see citing works
Holte, J., Bergh, T., Berne, C., & Lithell, H. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02577.x · Cited by 221 · see citing works
Edman, C. D., & MacDonald, P. C. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90288-0 · Cited by 206 · see citing works
RISK FACTORS FOR CARDIOVASCULAR MORTALITY IN MEXICAN AMERICANS AND NON-HISPANIC WHITES
Mitchell, B. D., Stern, M. P., Haffner, S. M., et al. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115517 · Cited by 204 · see citing works
Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries
Robinson, S., Henderson, A. D., Gelding, S. V., Kiddy, D. S., Niththyananthan, R., Bush, A., Richmond, W., Johnston, D. G., & Franks, S. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.674495.x · Cited by 181 · see citing works
Mather, K. J., Kwan, F., & Corenblum, B. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00468-9 · Cited by 177 · see citing works
Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome
Ovesen, P., Møller, J. K., Ingerslev, H. J., Jørgensen, J. O. L., Mengel, A., Schmitz, O., Alberti, K. G. M. M., & Møller, N. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263152 · Cited by 135 · see citing works
Wei, M., Mitchell, B. D., Haffner, S. M., & Stem, M. P. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008878 · Cited by 106 · see citing works
Turley, M., Skeaff, C. M., Mann, J. I., & Cox, B. (1998) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600634 · Cited by 101 · see citing works
GRAF, M. J., RICHARDS, C. J., BROWN, V., MEISSNER, L., & DUNAIF, A. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00472.x · Cited by 89 · see citing works
Self-citationAltered Composition of High Density Lipoproteins in Women with the Polycystic Ovary Syndrome1
Rajkhowa, M., Neary, R. H., Kumpatla, P., Game, F. L., Jones, P. W., Obhrai, M. S., & Clayton, R. N. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4318 · Cited by 88 · see citing works
Effects of Alcohol Consumption on Lipoproteins of Premenopausal Women
Clevidence, B. A., Reichman, M. E., Judd, J. T., Muesing, R. A., Schatzkin, A. G., Schaefer, E. J., Li, Z., Jenner, J. L., Brown, C., Sunkin, M. E., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.179 · Cited by 77 · see citing works
Legro, R. S., Kunselman, A. R., Dodson, W. C., & Dunaif, A. E. (1999) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199906000-00019 · Cited by 71 · see citing works
Self-citationSlowinska-Srzednicka, J., Zgliczyński, S., Wierzbicki, M., Srzednicki, M., Stopińska-Głuszak, U., Zgliczyński, W., Soszynski, P. A., Chotkowska, E., Bednarska, M., & Sadowski, Z. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03346870 · Cited by 70 · see citing works
Altered Composition of High Density Lipoproteins in Women with the Polycystic Ovary Syndrome
Rajkhowa, M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.10.3389 · Cited by 60 · see citing works
Legro, R. S., Blanche, P. J., Krauss, R. M., & Løbo, R. A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00401-x · Cited by 57 · see citing works
Self-citationAllhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_55 · Cited by 47 · see citing works
Serum cholesterol levels in a multiracial sample of 7,439 preschool children from Arizona
Freedman, D. S., Lee, S. L., Byers, T., Kuester, S., & Sell, K. (1992) · Preventive Medicine · doi:10.1016/0091-7435(92)90016-b · Cited by 27 · see citing works
Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome
von Eckardstein, S., von Eckardstein, A., Bender, H. G., Schulte, H., & Assmann, G. (1996) · Gynecological Endocrinology · doi:10.3109/09513599609012817 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · see citing works
Self-citationTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · see citing works
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · see citing works
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360 · see citing works
Self-citationCriteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · see citing works
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · see citing works
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · see citing works
Self-citationWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010 · see citing works
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676 · see citing works
Increased risk of depressive disorders in women with polycystic ovary syndrome
Hollinrake, E., Abreu, A., Maifeld, M., Van Voorhis, B. J., & Dokras, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.039 · Cited by 631 · see citing works
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01053.x · Cited by 539 · see citing works
Lipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.027 · Cited by 477 · see citing works
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466 · see citing works
Self-citationDetecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls
Legro, R. S., Castracane, V. D., & Kauffman, R. P. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000109523.25076.e2 · Cited by 453 · see citing works
Self-citationAssessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379 · see citing works
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362 · see citing works
Carmina, E., Bucchieri, S., Esposito, A., Del Puente, A., Mansueto, P., Orio, F., Di Fede, G., & Rini, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2725 · Cited by 317 · see citing works
Complications and challenges associated with polycystic ovary syndrome: current perspectives
Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287 · see citing works
Barber, T. M., Wass, J. A. H., McCarthy, M. I., & Franks, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02764.x · Cited by 254 · see citing works
Serum Vitamin D Levels and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
He, C., Lin, Z., Robb, S., & Ezeamama, A. (2015) · Nutrients · doi:10.3390/nu7064555 · Cited by 242 · see citing works
ACOG Practice Bulletin No. 194: polycystic ovary syndrome
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002656 · Cited by 231 · see citing works
Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites
Chen, W., & Pang, Y. (2021) · Metabolites · doi:10.3390/metabo11120869 · Cited by 228 · see citing works
Meyer, M. L., Malek, A. M., Wild, R. A., Korytkowski, M. T., & Talbott, E. O. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr046 · Cited by 175 · see citing works
Elkind-Hirsch, K. E., Chappell, N., Shaler, D., Storment, J., & Bellanger, D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.04.027 · Cited by 182 · see citing works
Vryonidou, A., Papatheodorou, A., Tavridou, A., Terzi, T., Loi, V., Vatalas, I.-A., Batakis, N., Phenekos, C., & Dionyssiou-Asteriou, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2363 · Cited by 171 · see citing works
Kite, C., Lahart, I. M., Afzal, I., Broom, D. R., Randeva, H., Kyrou, I., & Brown, J. E. (2019) · Systematic Reviews · doi:10.1186/s13643-019-0962-3 · Cited by 155 · see citing works
Physical activity and mental health in women with Polycystic Ovary Syndrome
Banting, L. K., Gibson-Helm, M., Polman, R., Teede, H. J., & Stepto, N. K. (2014) · BMC Women's Health · doi:10.1186/1472-6874-14-51 · Cited by 121 · see citing works
Cussons, A. J., Stuckey, B. G. A., Walsh, J. P., Burke, V., & Norman, R. J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02208.x · Cited by 119 · see citing works
Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108 · see citing works
Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., & Genazzani, A. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.004 · Cited by 95 · see citing works
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
Sam, S., & Ehrmann, D. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4306-3 · Cited by 93 · see citing works
Mechanisms IN endocrinology: metabolic syndrome through the female life cycle
Vryonidou, A., Paschou, S. A., Muscogiuri, G., Orio, F., & Goulis, D. G. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0275 · Cited by 88 · see citing works
Fux Otta, C., Wior, M., Iraci, G. S., Kaplan, R., Torres, D., Gaido, M. I., & Wyse, E. P. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903215581 · Cited by 85 · see citing works
Günalan, E., Yaba, A., & Yılmaz, B. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0077 · Cited by 74 · see citing works
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65 · see citing works
Moran, L. J., Hutchison, S. K., Meyer, C., Zoungas, S., & Teede, H. J. (2009) · Clinical Science · doi:10.1042/cs20080218 · Cited by 59 · see citing works
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa108 · Cited by 60 · see citing works
Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43 · see citing works
Park, K., Wei, J., Minissian, M., Bairey Merz, C. N., & Pepine, C. J. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6597-2 · Cited by 40 · see citing works
Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences
Kousta, E., Tolis, G., & Franks, S. (2005) · HORMONES · doi:10.14310/horm.2002.11151 · Cited by 35 · see citing works
Karamali, M., Ashrafi, M., Razavi, M., Jamilian, M., Akbari, M., & Asemi, Z. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-104530 · Cited by 34 · see citing works
Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes
Hong, S.-H., Hong, Y. S., Jeong, K., Chung, H., Lee, H., & Sung, Y.-A. (2020) · Scientific Reports · doi:10.1038/s41598-020-66633-2 · Cited by 32 · see citing works
The impact of ageing and menopause in women with polycystic ovary syndrome
Helvaci, N., & Yildiz, B. O. (2022) · Clinical Endocrinology · doi:10.1111/cen.14558 · Cited by 32 · see citing works
Xia, Y., Wang, Y., Cui, M., & Su, D. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1050 · Cited by 23 · see citing works
Body weight reduction and metformin: Roles in polycystic ovary syndrome
AL-Nozha, O., Habib, F., Mojaddidi, M., & El-Bab, M. F. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.03.002 · Cited by 20 · see citing works
Perelman, D., Coghlan, N., Lamendola, C., Carter, S., Abbasi, F., & McLaughlin, T. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1259407 · Cited by 18 · see citing works
Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence
Alesi, S., Ghelani, D., & Mousa, A. (2021) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1729841 · Cited by 16 · see citing works
Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin
Messer, C., Boston, R., Leroith, D., Geer, E., Miller, J. D., Messer, M., & Futterweit, W. (2012) · Endocrine Practice · doi:10.4158/ep11375.or · Cited by 16 · see citing works
Sex differences in androgen regulation of metabolism in nonhuman primates
True, C., Abbott, D. H., Roberts, C. T., & Varlamov, O. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_24 · Cited by 10 · see citing works
- Authors
- Legro, R. S., Kunselman, A. R., & Dunaif, A.
- Affiliations
- Pennsylvania State University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Dunaif, Andrea
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 111
- Issue
- 8
- Pages
- 607-613
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2021923144
- Cited by
- 622
- References
- 41
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 19 · 2023: 26 · 2022: 39 · 2021: 30 · 2020: 29 · 2019: 19 · 2018: 30 · 2017: 24 · 2016: 24 · 2015: 31 · 2014: 24 · 2013: 19 · 2012: 23
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605, DK-40605)
- National Center for Research Resources (RR02635, M01RR010732, RR-10732, M01RR002635)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-34449, U54HD034449, HD-0118)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- polycystic ovary syndrome, dyslipidemia, hypercholesterolemia, hypertriglyceridemia, hyperandrogenism, insulin resistance, obesity, body mass index, LDL cholesterol, HDL cholesterol, triglycerides, lipid metabolism disorders, risk factors, women's health, alcohol consumption, smoking, non-Hispanic white women, ethnic differences
- MeSH terms
- Adolescent, Adult, Androgens, Blood Glucose, Cholesterol, Female, Humans, Hyperlipidemias, Insulin, Lipids, Middle Aged, Polycystic Ovary Syndrome, Predictive Value of Tests, Regression Analysis, Risk Factors, Triglycerides, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review